2C-B-FLY (8-Bromo-2,3,6,7-benzodifuranyl-isopropylamine)

Category: Psychedelics. Status: Schedule I (research compound).

A "winged" relative of 2C-B with a longer, warmer experience. Notable for safety concerns around closely related compounds that have caused harm.

How it works

Activates serotonin 5-HT2A receptors.

Key facts

• Molecular weight: 296.16 g/mol
• Half-life: Moderate
• Bioavailability: Oral
• Storage: Research/reference only.

Dosing overview

• Typical dose: Varies by individual and setting
• Frequency: Occasional
• Duration: Acute effects last 6-10 hours
• Route: Oral

Protocol notes

• Taken orally in measured doses for a warm, longer experience than 2C-B.
• Easily confused with a toxic look-alike, so source and identity matter a lot.

Reported benefits

• Warm, sensual experience
• Longer than 2C-B
• Phenethylamine research compound
• Distinct "FLY" structure

Possible side effects

• Easily confused with toxic analogs
• Nausea
• Raised heart rate
• Limited human safety data

Compare 2C-B-FLY

• 2C-B-FLY vs MDMA
• 2C-B-FLY vs Psilocybin
• 2C-B-FLY vs LSD
• 2C-B-FLY vs Ibogaine
• 2C-B-FLY vs DMT
• 2C-B-FLY vs Ayahuasca

Research and educational reference only. Not medical advice.